As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...